Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPH [NASD]
Amphastar Pharmaceuticals, Inc.
Index- P/E398.40 EPS (ttm)0.05 Insider Own6.00% Shs Outstand47.52M Perf Week6.01%
Market Cap942.42M Forward P/E14.34 EPS next Y1.39 Insider Trans-12.32% Shs Float36.41M Perf Month4.40%
Income2.50M PEG15.94 EPS next Q0.21 Inst Own55.90% Short Float7.15% Perf Quarter2.89%
Sales368.20M P/S2.56 EPS this Y-97.10% Inst Trans0.62% Short Ratio15.20 Perf Half Y5.45%
Book/sh8.53 P/B2.34 EPS next Y39.46% ROA0.40% Target Price21.60 Perf Year1.37%
Cash/sh2.43 P/C8.19 EPS next 5Y25.00% ROE0.60% 52W Range16.91 - 22.69 Perf YTD-0.94%
Dividend- P/FCF20.90 EPS past 5Y19.70% ROI1.70% 52W High-12.21% Beta0.72
Dividend %- Quick Ratio1.60 Sales past 5Y6.80% Gross Margin41.10% 52W Low17.80% ATR0.51
Employees1980 Current Ratio2.40 Sales Q/Q21.60% Oper. Margin3.70% RSI (14)64.37 Volatility2.77% 2.42%
OptionableYes Debt/Eq0.11 EPS Q/Q24.40% Profit Margin0.70% Rel Volume1.43 Prev Close19.70
ShortableYes LT Debt/Eq0.08 EarningsMay 06 AMC Payout0.00% Avg Volume171.36K Price19.92
Recom2.60 SMA202.54% SMA508.09% SMA2005.17% Volume244,813 Change1.12%
Jan-08-21Downgrade Wells Fargo Overweight → Equal Weight $21
Oct-05-20Upgrade Northland Capital Market Perform → Outperform $24
May-01-20Initiated Northland Capital Outperform $23
Mar-13-19Downgrade Piper Jaffray Overweight → Neutral $24 → $23
Mar-13-19Downgrade Needham Buy → Hold
Aug-10-18Reiterated Needham Buy $24 → $22
Mar-13-18Reiterated Needham Buy $23 → $24
Dec-01-17Reiterated Needham Buy $20 → $23
Nov-09-17Downgrade Raymond James Outperform → Mkt Perform
Sep-27-17Reiterated Needham Buy $18 → $20
Mar-14-17Downgrade Raymond James Strong Buy → Outperform
Aug-09-16Reiterated Needham Buy $20 → $22
May-10-16Reiterated Needham Buy $21 → $20
Feb-19-16Initiated Wells Fargo Outperform
Jun-19-15Reiterated Needham Buy $17 → $21
Jun-03-15Initiated Raymond James Strong Buy
Jul-21-14Initiated Needham Buy $17
Jun-01-21 05:13AM  
May-27-21 06:00AM  
May-07-21 04:05PM  
10:00AM  
May-06-21 06:25PM  
04:05PM  
May-03-21 06:00AM  
Apr-29-21 05:06PM  
06:00AM  
Apr-13-21 09:02AM  
Apr-09-21 01:14AM  
Apr-06-21 04:05PM  
Mar-30-21 08:14AM  
Mar-29-21 06:00AM  
Mar-18-21 08:05AM  
Mar-15-21 08:30PM  
05:35PM  
05:00PM  
04:05PM  
02:45AM  
Mar-08-21 05:39PM  
Mar-04-21 12:30PM  
Feb-26-21 06:01AM  
Feb-07-21 11:23PM  
Dec-29-20 09:10AM  
08:38AM  
08:09AM  
06:00AM  
Dec-24-20 11:46PM  
Dec-11-20 08:55AM  
Dec-07-20 10:56AM  
Dec-03-20 09:25PM  
Nov-06-20 05:00PM  
10:45AM  
09:05AM  
07:52AM  
06:50AM  
Nov-05-20 10:06AM  
Oct-30-20 12:30PM  
Oct-29-20 04:05PM  
Oct-23-20 12:45PM  
Oct-14-20 07:26AM  
06:10AM  
Oct-07-20 12:45PM  
Oct-06-20 06:00AM  
Oct-05-20 10:44AM  
Sep-08-20 06:59AM  
Sep-03-20 04:05PM  
Aug-06-20 04:05PM  
Aug-05-20 12:18PM  
Aug-03-20 08:05AM  
Jul-30-20 04:05PM  
Jul-29-20 12:33PM  
Jul-03-20 11:59AM  
Jun-19-20 06:05AM  
Jun-12-20 04:17PM  
06:30AM  
Jun-09-20 09:52AM  
06:00AM  
Jun-02-20 04:05PM  
May-11-20 01:24AM  
May-09-20 08:21AM  
May-08-20 04:31PM  
May-07-20 04:05PM  
May-06-20 12:10PM  
May-04-20 06:01AM  
Apr-27-20 06:00AM  
Apr-13-20 05:16PM  
Apr-09-20 06:01AM  
Mar-31-20 10:56AM  
Mar-29-20 08:36AM  
Mar-25-20 09:33AM  
Mar-24-20 09:47AM  
Mar-20-20 10:44AM  
Mar-12-20 06:05PM  
04:05PM  
03:00PM  
Mar-05-20 04:05PM  
Mar-03-20 12:30PM  
Feb-27-20 06:00AM  
Feb-13-20 05:48AM  
Jan-29-20 08:30AM  
Jan-28-20 04:05PM  
Jan-08-20 05:15AM  
Dec-17-19 07:19PM  
Dec-10-19 10:25PM  
Dec-02-19 05:16AM  
Nov-27-19 06:00AM  
Nov-15-19 06:00AM  
Nov-07-19 04:05PM  
Nov-01-19 06:00AM  
Oct-28-19 02:14PM  
Oct-21-19 06:17AM  
Sep-21-19 07:58AM  
Sep-12-19 09:15PM  
Sep-01-19 09:38PM  
Aug-29-19 06:01AM  
Aug-22-19 08:44AM  
Aug-07-19 11:24PM  
08:55PM  
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhou RongEVP, Production CenterJun 09Sale19.584,73292,65386,244Jun 10 04:45 PM
Lee HowardDirectorJun 08Option Exercise16.438,000131,440146,933Jun 08 08:56 PM
Zhou RongEVP, Production CenterJun 08Option Exercise14.238,180116,40199,156Jun 10 04:45 PM
Zhou RongEVP, Production CenterJun 08Sale19.348,180158,17790,976Jun 10 04:45 PM
Lee HowardDirectorJun 08Sale19.318,000154,508138,933Jun 08 08:56 PM
PRINS RICHARD KDirectorJun 07Option Exercise16.435,00082,15044,160Jun 08 08:59 PM
Petersen Floyd F.DirectorJun 07Option Exercise16.4315,827260,03889,181Jun 08 08:58 PM
Lee HowardDirectorJun 07Option Exercise16.437,827128,598140,741Jun 08 08:56 PM
Lee HowardDirectorJun 07Sale19.287,827150,941132,914Jun 08 08:56 PM
Petersen Floyd F.DirectorJun 07Sale19.3415,827306,03973,354Jun 08 08:58 PM
PRINS RICHARD KDirectorJun 07Sale18.705,00093,50039,160Jun 08 08:59 PM
PRINS RICHARD KDirectorJun 04Option Exercise16.435,00082,15044,160Jun 08 08:59 PM
PRINS RICHARD KDirectorJun 04Sale18.775,00093,85139,160Jun 08 08:59 PM
Petersen Floyd F.DirectorJun 03Option Exercise16.4310,000164,30083,354Jun 04 07:35 PM
Petersen Floyd F.DirectorJun 03Sale18.6510,000186,52773,354Jun 04 07:35 PM
Koo RichardDirectorJun 01Option Exercise16.4325,827424,338279,097Jun 02 07:34 PM
Koo RichardDirectorJun 01Sale19.2825,827498,009253,270Jun 02 07:34 PM
Lee HowardDirectorMay 20Option Exercise16.4310,000164,300142,914May 24 04:45 PM
Lee HowardDirectorMay 20Sale19.7410,000197,354132,914May 24 04:45 PM
Liawatidewi YakobSVP Corp Admin CenterMay 17Option Exercise11.339,637109,18763,210May 18 04:06 PM
Liawatidewi YakobSVP Corp Admin CenterMay 17Sale19.999,637192,68653,573May 18 04:06 PM
Zhou RongEVP, Production CenterMay 14Option Exercise14.2311,120158,238107,385May 17 07:38 PM
Liawatidewi YakobSVP Corp Admin CenterMay 14Sale19.923,18663,45453,573May 18 04:06 PM
Zhou RongEVP, Production CenterMay 14Sale19.7217,419343,46489,966May 17 07:38 PM
Zhou RongEVP, Production CenterMay 13Option Exercise14.237009,96196,965May 17 07:38 PM
ZASLOFF MICHAEL ADirectorMay 13Option Exercise16.4325,827424,33867,014May 14 07:01 PM
ZASLOFF MICHAEL ADirectorMay 13Sale19.3425,827499,43541,187May 14 07:01 PM
Zhou RongEVP, Production CenterMay 13Sale19.5870013,70696,265May 17 07:38 PM
Liawatidewi YakobEVP Corp Admin CenterMay 12Sale19.334,59288,74256,759May 13 06:39 PM
Liawatidewi YakobEVP Corp Admin CenterMay 11Option Exercise11.3310,000113,30071,351May 13 06:39 PM
PRINS RICHARD KDirectorMay 11Option Exercise16.4315,827260,03854,987May 13 06:42 PM
Liawatidewi YakobEVP Corp Admin CenterMay 11Sale19.0610,000190,59761,351May 13 06:39 PM
PRINS RICHARD KDirectorMay 11Sale18.9015,827299,11039,160May 13 06:42 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 15Sale19.034,24480,74585,304Mar 17 07:40 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 18Sale18.584077,5626,827,679Feb 18 06:58 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 17Sale18.6713,801257,7236,828,086Feb 18 06:58 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 16Sale18.5116,259301,0316,841,887Feb 18 06:58 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 12Sale18.9413,277251,5226,858,146Feb 12 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 11Sale19.0619,823377,8846,871,423Feb 12 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 10Sale18.7615,747295,3446,891,246Feb 12 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 09Sale18.9311,927225,7766,906,993Feb 09 05:30 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 08Sale18.8913,452254,0496,918,920Feb 09 05:30 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 05Sale18.9415,507293,7216,932,372Feb 09 05:30 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 04Sale18.8925,570483,0206,947,879Feb 05 08:35 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 03Sale18.3616,299299,3236,973,449Feb 05 08:35 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 02Sale18.6613,817257,8216,989,748Feb 03 04:15 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 01Sale18.2924,114441,1207,003,565Feb 03 04:15 PM
Petersen Floyd F.DirectorFeb 01Sale18.2663911,66973,354Feb 02 04:16 PM
PETERS WILLIAM JCFO, SVP & TreasurerJan 19Sale18.676,495121,23789,548Jan 20 05:58 PM
Petersen Floyd F.DirectorDec 01Sale17.875008,93673,993Dec 02 04:20 PM
Petersen Floyd F.DirectorNov 02Sale19.845009,92074,493Nov 03 04:05 PM
Petersen Floyd F.DirectorOct 01Sale18.895009,44674,993Oct 02 04:15 PM
Petersen Floyd F.DirectorSep 01Sale19.905009,94875,493Sep 02 05:27 PM
Maris DavidDirectorAug 14Buy20.261,00020,26013,151Aug 18 04:15 PM
PETERS WILLIAM JCFO, SVP & TreasurerAug 14Sale20.365,512112,22395,652Aug 18 04:12 PM
PRINS RICHARD KDirectorAug 11Sale20.336,000121,97639,160Aug 12 06:34 PM
Petersen Floyd F.DirectorAug 03Sale20.6250010,30875,993Aug 04 08:22 PM
Liawatidewi YakobEVP Corp Admin CenterJul 21Option Exercise11.335,97867,73151,974Jul 22 06:28 PM
Liawatidewi YakobEVP Corp Admin CenterJul 21Sale21.225,978126,83745,996Jul 22 06:28 PM
Liawatidewi YakobEVP Corp Admin CenterJul 20Option Exercise11.334,18647,42750,182Jul 22 06:28 PM
Liawatidewi YakobEVP Corp Admin CenterJul 20Sale21.034,18688,04745,996Jul 22 06:28 PM
PETERS WILLIAM JCFO, SVP & TreasurerJul 06Option Exercise11.3310,000113,300114,820Jul 08 04:05 PM
PETERS WILLIAM JCFO, SVP & TreasurerJul 06Sale22.0013,656300,405101,164Jul 08 04:05 PM
Petersen Floyd F.DirectorJul 01Sale22.2750011,13676,493Jul 02 07:36 PM